Nasdaq:US$17.54 (-0.39) | HKEX:HK$26.92 (-0.76) | AIM:£2.50 (-0.1)
Other Ventures

Separate from our Oncology/Immunology R&D and commercial operations, our Other Ventures segment mainly provides Shanghai logistics and distribution services to third-party pharmaceutical companies.

This business is operated through a Good Supply Practice-certified joint venture that is 51% owned by HUTCHMED and 49% owned by Sinopharm, a leading distributor of pharmaceutical and healthcare products and a leading supply chain service provider in China.

Our Other Ventures also includes a 5% interest in Shanghai Hutchison Pharmaceuticals, which manufactures, markets and distributes a range of its own-brand prescription drug products across mainland China.